Announcement on holding the 2024 and the first quarter of 2025 results briefing
China Pharmaceutical: Announcement of Resolutions of the 26th Meeting of the 9th Board of Directors
China Pharmaceutical: Assessment Report on the equity value assets of all shareholders of Beijing Jinsui Technology Development Co., Ltd. involved in the Beijing Jinsui Technology Development Co., Ltd. equity project held by China Healthcare Industry Co., Ltd. to acquire Beijing Jinsui Technology Development Co., Ltd. shares held by China Xinxing Group Co., Ltd.
China Pharmaceuticals: Beijing Jinsui Technology Development Co., Ltd. audit reports for 2024-1-6, 2023, 2022, and 2021
China Pharmaceutical: Beijing Jinsui Technology Development Co., Ltd. Audit Report for November 2021 to 2024
Beijing Jinsui Technology Development Co., Ltd. Audit Report for November 2021 to 2024
Audit reports of Beijing Jinsui Technology Development Co., Ltd. from January to June 2024, 2023, 2022 and 2021
Announcement of Resolutions of the 26th Meeting of the 9th Board of Directors
China Pharmaceuticals: Announcement on Subsidiary Pharmaceuticals Obtaining CEP Certificates
2024 Internal Control Audit Report
Announcement on providing guarantees for holding companies in 2025
Announcement on renewing the employment of accounting firms in 2025
Report on the work of the Board of Supervisors 2024
Announcement of Resolutions of the 12th Meeting of the 9th Board of Supervisors
Announcement on applying for a comprehensive credit line and related transactions from the Group Finance Company in 2025
Environmental, Social and Corporate Governance (ESG) Management Measures
Announcement of Resolutions of the 24th Meeting of the 9th Board of Directors
Announcement on the actual completion of the company\'s daily related transactions in 2024 and the forecast for 2025
Special instructions for financial services such as deposits and loans involving transactions related to finance companies
2024 Environmental, Social and Corporate Governance (ESG) Report